719P Correlative Serum Biomarker Analyses: Lenvatinib (LEN) Plus Pembrolizumab (PEMBRO) in a Phase Ib/II Trial in Advanced Renal Cell Carcinoma (RCC)
ANNALS OF ONCOLOGY（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined